- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03046368
Personalization of Cover Letter and Response Rate
Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and aim: In the Danish Health and Morbidity Surveys the participation rate has declined from 61% in 2010 to 57% in 2013. A declining participation rate may affect the representativeness and the results of the survey. Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. The research question, then, is whether cover letters with targeted content can perform better than a standard letter. The proposition is that such letters should increase the willingness of some sample members to participate, and that this will be reflected in higher response rates. However, little is known about which targeted content is the most effective.
Thus, in the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys. Further, given that the majority of sample members participate, these sample members who are swayed by the targeted letter must have relatively low response propensities (with the standard letter). Thus, we hypothesize that targeted letters should particularly improve response rates in low response propensity subgroups (i.e. young men, unmarried, and elderly women). A secondary research question is, therefore, whether any effect of targeted letters on response rate is greater among sample subgroups with low response propensities.
Design: A randomized trial will be incorporated the Danish Health and Morbidity Survey 2017 where a paragraph in the cover letter intended to heighten perceptions of relevance of the survey is varied among sample members. The Danish Health and Morbidity Survey 2017 will be based on a nationally representative random sample of 25,000 individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017. The sample will be drawn from the adult population in Denmark using the Danish Civil Registration System and the survey will be conducted between February 3 and Maj 5, 2017. All sample members will be randomly allocated, with equal probabilities, to one of 11 treatment groups. One group will receive a standard letter that is designed to have general appeal and the other 10 groups will receive one of 10 versions of the targeted cover letter. In the previous Health and Morbidity Surveys, all sample members received the same standard letter. Much of the content of the standard letter and the targeted letter will be the same. The intention is to hold constant features designed to demonstrate the credibility of the survey, to allay fears about confidentiality, to appeal to self-interest, and to provide basic information about the task of participation. All sample members will be invited either to complete a web questionnaire or to fill out a paper questionnaire concerning health and morbidity.
Statistics: The analysis will be based on logistic regression modelling of the 25,000 persons invited to the Health and Morbidity Survey 2017. The independent variable is a dichotomous indicator of treatment group: targeted or standard letter. The dependent variable indicates whether the sample member has fully or partially completed the questionnaire. The mediator variable indicates membership of each of three operationally important low response propensity groups (i.e. young men, unmarried, and elderly women). The approach is to first test for a main effect of the independent variable in each of the treatment groups. A second step is to conduct the same analysis stratified by treatment group. A third step will then seek to identify whether any significant effects occurs between the mediator variable and dependent variable.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 1353
- National Institute of Public Health, University of Southern Denmark
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Standard cover letter
The group will receive a standard cover letter to the survey that is designed to have broad appeal: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. |
|
|
EXPERIMENTAL: Targeted cover letter 1
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sleep problems. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 2
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 3
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sex |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 4
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 5
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and sex. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 6
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sex and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 7
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 8
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and alcohol. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 9
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, alcohol and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
|
EXPERIMENTAL: Targeted cover letter 10
This group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as alcohol, sleep problem and contact to family and friends. |
The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall response rate
Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
|
Response rate overall and in the different intervention arms
|
Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Response rate in different subgroups
Time Frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
|
Response rate in different subgroups with low response propensity
|
Up to 3 months (from February 3 2017 to maxium Maj 5 2017)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Janne S Tolstrup, MD PhD, National Institute of Public Health - University of Southern Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 60110-5060-FL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Response Rate
-
Shanghai Jiao Tong University School of MedicineCompleted
-
Qingdao Central HospitalRecruitingOverall Response RateChina
-
Peking Union Medical College HospitalOrigiMedRecruitingQuality of Life | Objective Response Rate | Overall Survival | Progression-free Survival | Disease Control Rate | Duration of Response | Five-year Survival RateChina
-
Universidade Federal do Triangulo MineiroCompletedBlood Pressure | Heart Rate | Hemodynamic Response | Rating of Perceived ExertionBrazil
-
The Second Affiliated Hospital of Hainan Medical...RecruitingQuality of Life | Radiation Toxicity | Oncology | Overall Response RateChina
-
Sun Yat-sen UniversityNot yet recruitingObjective Response Rate | Head and Neck Cancer Squamous Cell Carcinoma | Neoadjuvant Chemoimmunotherapy | Skull Base--CancerChina
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedAdverse Events | Progress-free Survival | Overall Response Rate
-
The Second Hospital of Shandong UniversityRecruitingQuality of Life | Objective Response Rate | Immune-related Adverse Events | Pathological Complete RemissionChina
-
InCor Heart InstituteConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedOxidative Stress | Heart Rate Variability | Systemic Inflammatory Response | Lung FunctionBrazil
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Rate Variability | Blood Pressure Variability | Pressor Response | Baroreflex Sensitivity | Arterial CatecholaminesUnited States
Clinical Trials on Targeted cover letter
-
US Department of Veterans AffairsCompletedProblem Behavior | Dementia, Alzheimer TypeUnited States
-
Southern California Institute for Research and...Samueli Institute for Information BiologyCompletedPhantom Limb PainUnited States
-
University of California, IrvineCompletedBack Pain | InsomniaUnited States
-
The Cleveland ClinicCompletedConflicts of Interest
-
Public Health EnglandWithdrawnInfluenza, Human
-
University of Paris 5 - Rene DescartesHotel Dieu Hospital; Société de Formation Thérapeutique du Généraliste; Adeca 75Unknown
-
Weizhuo YiCompletedSchizophrenia Relapse | Light PollutionChina
-
Universitätsklinikum Hamburg-EppendorfCompletedRole-expectancy on Patient Reported OutcomesGermany
-
Osiris TherapeuticsTerminated
-
Case Western Reserve UniversityNational Institute of Dental and Craniofacial Research (NIDCR); University... and other collaboratorsCompleted